![NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aaz2738/asset/00b4df9f-5315-42a6-be35-aabb15baf87e/assets/graphic/aaz2738-f2.jpeg)
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology
![Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6488306/bin/nihms-1509345-f0006.jpg)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC
![PDF) Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors PDF) Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors](https://i1.rgstatic.net/publication/355976800_Powerful_synergistic_effects_of_a_STING_agonist_and_an_IL-2_superkine_in_cancer_immunotherapy_against_MHC_I-deficient_and_MHC_I_tumors/links/638165e9c2cb154d292970e6/largepreview.png)
PDF) Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors
![Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6488306/bin/nihms-1509345-f0005.jpg)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC
![Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6488306/bin/nihms-1509345-f0001.jpg)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. - Abstract - Europe PMC
![NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology](https://www.science.org/cms/asset/e9264f39-9bd1-4845-9376-dbbbd6ce2fcb/aaz2738-f1.gif)
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology
![NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aaz2738/asset/888eb16a-031a-48ff-97e1-9ccb00a68bb6/assets/graphic/aaz2738-f4.jpeg)
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology
![NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.aaz2738/asset/6fbf89c6-e968-4784-af1e-9fb19579388d/assets/graphic/aaz2738-f3.jpeg)